Ommaya Reservoirs for the Treatment of Leptomeningeal Metastases
- 1 July 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 47 (1) , 49-55
- https://doi.org/10.1097/00006123-200007000-00011
Abstract
Ommaya reservoirs are frequently used to deliver intraventricular chemotherapy in cancer patients with leptomeningeal metastases. We review techniques of catheter placement and complication avoidance. Between January 1995 and June 1998, Ommaya reservoirs were placed in 107 patients for the treatment or prophylaxis of leptomeningeal metastases at the Memorial Sloan-Kettering Cancer Center. Patients with slit ventricles (total, 25) underwent preoperative pneumoencephalography for ventricular dilation. Intraoperative fluoroscopic guidance was used in 77 patients to confirm the catheter tip position at the foramen of Monro. Other intraoperative aids included endoscopy in 21 patients, ultrasound in 7, and stereotaxy in 6. No aids were used in 3 patients, more than one aid was used in 9, and the technique could not be determined retrospectively in 3. The median survival of patients treated for leptomeningeal metastases was 9 months (Kaplan-Meier method). Eight patients developed hydrocephalus requiring conversion of the Ommaya reservoir to a ventriculoperitoneal shunt and precluding delivery of chemotherapeutic agents. An additional 11 patients referred for Ommaya reservoir placement demonstrated elevated intracranial pressure requiring an initial ventriculoperitoneal shunt. Complications of Ommaya reservoir placement occurred in 10 patients (9.3%) and included two infections, five catheter malpositions, and three intracranial hemorrhages. Two deaths occurred secondary to intracranial hemorrhage: one after postoperative anticoagulation for a mechanical heart valve, and one attributed to treatment-related thrombocytopenia. Nine patients (8.4%) had treatment-related imaging abnormalities; seven were asymptomatic and two developed symptomatic leukoencephalopathy. Complications associated with Ommaya reservoirs can be minimized by intraoperative confirmation of the catheter position with fluoroscopic guidance and/or endoscopy. We recommend postoperative computed tomographic scans before initiation of intraventricular chemotherapy. Patients with elevated intracranial pressure may require shunting procedures in lieu of Ommaya reservoir placement.Keywords
This publication has 21 references indexed in Scilit:
- Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastasesJournal of Neurosurgery, 1997
- Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barre syndromeNeurology, 1996
- Leptomeningeal CarcinomatosisArchives of Neurology, 1996
- Prognostic significance of sup 111 Indium-DTPA CSF flow studies in leptomeningeal metastasesNeurology, 1996
- Leptomeningeal tumor in primarchy central nervous system lymphoma: Recognition, significance, and implicationsAnnals of Neurology, 1995
- Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasisAnnals of Neurology, 1995
- A guide for ventricular catheter placementJournal of Neurosurgery, 1985
- Intraventricular versus intralumbar methotrexate for central‐nervous‐system leukemia: Prolonged remission with the ommaya reservoirMedical and Pediatric Oncology, 1979
- The ommaya reservoir.Newly recognized complications and recommendations for insertion and useCancer, 1978
- Ommaya Device in Carcinomatous and Leukemic Meningitis: Surgical Experience in 45 CasesSurgical Clinics of North America, 1974